Literature DB >> 12030843

Oxygen toxicity in premature infants.

Barry Weinberger1, Debra L Laskin, Diane E Heck, Jeffrey D Laskin.   

Abstract

Oxygen causes tissue injury through the formation of reactive oxygen intermediates and peroxidation of membrane lipids. Premature infants, who have severely reduced antioxidant defenses, are particularly sensitive to the toxic effects of oxygen. Supplemental oxygen in premature infants contributes to the development of chronic lung disease (bronchopulmonary dysplasia), characterized by dysregulated inflammation and altered expression of proteases and growth factors. This can result in fibrosis, asymmetric aeration, and respiratory insufficiency. Oxygen also induces aberrant physiologic responses that can be damaging in premature infants. For example, vasoconstriction in the retina is an early response to oxygen that can lead to vasoobliteration, neovascularization, and retinal traction (retinopathy of prematurity). Increasing knowledge of the mechanisms underlying oxygen toxicity in premature infants has suggested strategies to minimize tissue injury and to optimize long-term medical outcomes. These include limiting oxygen supplementation and light exposure, the use of antiinflammatory agents or antioxidants, and the use of room air in neonatal resuscitation. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030843     DOI: 10.1006/taap.2002.9387

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  34 in total

1.  Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice.

Authors:  Bradley W Buczynski; Min Yee; B Paige Lawrence; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-09       Impact factor: 5.464

2.  Efforts in trying to better define the level of evidence on topical pressurised oxygen therapy (TPOT) for wound healing.

Authors:  Richard Belley; Dominique Buteau; Marie-Ludivine Chateau-Degat
Journal:  Int Wound J       Date:  2012-06-27       Impact factor: 3.315

Review 3.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

Review 4.  Home oxygen for children: who, how and when?

Authors:  I M Balfour-Lynn; R A Primhak; B N J Shaw
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 5.  Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified.

Authors:  Marvin Heyboer; Deepali Sharma; William Santiago; Norman McCulloch
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-06-01       Impact factor: 4.730

6.  Cancer risk among children with very low birth weights.

Authors:  Logan G Spector; Susan E Puumala; Susan E Carozza; Eric J Chow; Erin E Fox; Scott Horel; Kimberly J Johnson; Colleen C McLaughlin; Peggy Reynolds; Julie Von Behren; Beth A Mueller
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

Review 7.  Hereditary influences in oxygen-induced retinopathy in the rat.

Authors:  Peter van Wijngaarden; Helen M Brereton; Douglas J Coster; Keryn A Williams
Journal:  Doc Ophthalmol       Date:  2009-09-19       Impact factor: 2.379

8.  Tyrosine phosphorylation of apoptotic proteins during hyperoxia in mitochondria of the cerebral cortex of newborn piglets.

Authors:  Manjula Mudduluru; Alan B Zubrow; Q M Ashraf; Maria Delivoria-Papadopoulos; Om P Mishra
Journal:  Neurochem Res       Date:  2010-03-09       Impact factor: 3.996

Review 9.  The role of hyperoxia in the pathogenesis of experimental BPD.

Authors:  Bradley W Buczynski; Echezona T Maduekwe; Michael A O'Reilly
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.